Zelig Eshhar

13.9k citations
178 papers · 11.0k · 3 hit papers · h-index 53

Impact in

  • Oncology top 0.2%
    • CAR-T cell therapy research
  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

Zelig Eshhar

177 papers receiving 10.6k citations

Hit Papers

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer 2006 · 984 citations
9840+12+24Years since publication4008001.2k

Peers

Zelig Eshhar
Comparison fields: 5 of 129
  • Oncology 6.6k
  • Immunology 4.7k
  • Radiology, Nuclear Medicine and Imaging 2.4k
  • Genetics 2.2k
  • Molecular Biology 3.7k
Replace Winfried S. Wels with:
Winfried S. Wels Germany
Catia Traversari Italy
I. Jolanda M. de Vries Netherlands
Stephen D. Gillies United States
Andrew Raubitschek United States
Gerd Ritter United States
G. Yancey Gillespie United States
John R. Wunderlich United States
Christoph Rader United States
Gustav Gaudernack Norway
Zelig Eshhar relative to Winfried S. Wels Germany Winfried S. Wels's profile →
Citations per field
00.5×1.5×
Winfried S. Wels · 1×
Citations per year

Countries citing papers authored by Zelig Eshhar

Since Specialization
Citations

This map shows the geographic impact of Zelig Eshhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelig Eshhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelig Eshhar more than expected).

Fields of papers citing papers by Zelig Eshhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelig Eshhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelig Eshhar. The network helps show where Zelig Eshhar may publish in the future.

Co-authors

The 25 scholars most cited alongside Zelig Eshhar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zelig Eshhar Line = papers co-authored together Zelig Eshhar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
Hit paper breakdown →
19931248
2
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.
Hit paper breakdown →
19891169
3
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Hit paper breakdown →
2006984
4 2009239
5
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
1995226
6 1993207
7 1982205
8 2014189
9 1993169
10 2003169
11 1981150
12 2008149
13 1980144
14 2009143
15 1982137
16 2000135
17 2016119
18 1984118
19
Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity.
1989117
20 1985117

About Zelig Eshhar

Zelig Eshhar is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Oncology and Biomedical Engineering, having authored 178 papers that have together received 11.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (96 papers), CAR-T cell therapy research (59 papers), T-cell and B-cell Immunology (34 papers), Immune Cell Function and Interaction (28 papers), Immunotherapy and Immune Responses (27 papers), Glycosylation and Glycoproteins Research (23 papers), Protein purification and stability (18 papers) and Chemical Synthesis and Analysis (12 papers). The work is most often cited by research in Oncology (6.6k citations), Immunology (4.7k citations), Radiology, Nuclear Medicine and Imaging (2.4k citations), Genetics (2.2k citations) and Molecular Biology (3.7k citations). Zelig Eshhar has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Tova Waks, G. Gross, Daniel Schindler, Steven A. Rosenberg, Gideon Gross, James C. Yang, Patrick Hwu, Eran Elinav, Michal Baniyash and Silvana Canevari. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, European Journal of Immunology, Molecular Immunology and European Journal of Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact